IRONWOOD PHARMACEUTICALS INC (IRWD)
US46333X1081 - Common Stock
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
First Week of June 21st Options Trading For Ironwood Pharmaceuticals (IRWD)
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.
Noteworthy Thursday Option Activity: VEEV, GLNG, IRWD
Oversold Conditions For Ironwood Pharmaceuticals (IRWD)
Ironwood plunges nearly 40% after SBS trial misses secondary goals (NASDAQ:IRWD)
Ironwood Pharmaceuticals shares dropped 38.3% despite positive Phase 3 trial results for their SBS drug candidate apraglutide.
PSNY Stock Alert: Polestar Makes Moves With Its Joint Venture
Polestar stock is rising higher on Thursday as holders of PSNY shares react to an update for the company's Chinese joint venture.
Ironwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All
The company still plans to ask for approval of its short bowel syndrome treatment.
Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?
Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
Interesting IRWD Put And Call Options For March 15th
Ironwood Pharmaceuticals expects 2024 revenue to be below consensus (NASDAQ:IRWD)
Ironwood Pharmaceuticals expects its 2024 revenue to range between $435M-$455M, below consensus estimates, while maintaining its 2023 revenue guidance.
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
UPS, CRWD and TOL among Wells Fargo's 11 overweight tactical ideas
On Tuesday, Wells Fargo's equity research team outlined it's 2024 first quarter tactical high conviction trade ideas. Learn ore here.
Noteworthy Wednesday Option Activity: JBLU, IRWD, MDLZ
First Week of August 2024 Options Trading For Ironwood Pharmaceuticals (IRWD)
Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
Ironwood Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for IRWD
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
Dallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to...
